TSO3 (TSE:TOS) Shares Down 13.3%

TSO3 Inc. (TSE:TOS) shares were down 13.3% during mid-day trading on Thursday . The stock traded as low as C$0.38 and last traded at C$0.39. Approximately 107,270 shares traded hands during trading, a decline of 1% from the average daily volume of 108,684 shares. The stock had previously closed at C$0.45.

Separately, Desjardins reissued a “hold” rating on shares of TSO3 in a research note on Sunday, March 31st.

The company has a market capitalization of $28.05 million and a PE ratio of -3.15. The company has a current ratio of 6.33, a quick ratio of 4.83 and a debt-to-equity ratio of 894.59.

TSO3 (TSE:TOS) last issued its earnings results on Monday, May 6th. The company reported C($0.05) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of C($0.05). The company had revenue of C$1.28 million for the quarter. Equities analysts anticipate that TSO3 Inc. will post -0.08 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece was reported by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this piece on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The original version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/06/15/tso3-tsetos-shares-down-13-3.html.

About TSO3 (TSE:TOS)

TSO3 Inc engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices worldwide. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States.

Featured Story: What does an equal weight rating mean?

Receive News & Ratings for TSO3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 and related companies with MarketBeat.com's FREE daily email newsletter.